Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hereditary Hemorrhagic Telangiectasia: early-phase trial registry
2 of 8 indexed Hereditary Hemorrhagic Telangiectasia trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · 2 currently recruiting · #2,176 of 28,707 conditions by registered trial count
Hereditary Hemorrhagic Telangiectasia: 8 US clinical trials tracked, 2 recruiting.
Hereditary Hemorrhagic Telangiectasia is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is Cure HHT, running 2 of these trials.
Enrollment posture brief
Registry condition hereditary-hemorrhagic-telangiectasia
OPEN 2 | RECR 25% | LATE 0 | EARLY 5 | RANK #2176 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Abdominal Pain (25% recruiting · 20 trials)
Hereditary Hemorrhagic Telangiectasia lists 2 open slots (25% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hereditary Hemorrhagic Telangiectasia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hereditary Hemorrhagic Telangiectasia is recruiting below its size-band peers.
2 of 8 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Hereditary Hemorrhagic Telangiectasia research.
Cure HHT accounts for 2 of 8 trials (25%). 7 distinct sponsors appear on at least one study for this condition label.
-
Most Hereditary Hemorrhagic Telangiectasia trials plan to enrol fewer than 100 people.
Median target enrolment is 70 among the 8 trials that report a genuine target (sentinel values excluded). 5 of those (62.5%) plan for fewer than 100 participants.
-
Hereditary Hemorrhagic Telangiectasia splits between interventional and observational designs.
5 interventional and 3 observational studies make up this index (62.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
8 total, page 1 of 1
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
Cure HHT
NCT06259292
A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Alnylam Pharmaceuticals
NCT06659640
Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia
Unity Health Toronto
NCT01158807
Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz)
Cure HHT
NCT03850964
Bevacizumab In Hereditary Hemorrhagic Telangiectasia
Hanny Al-Samkari, MD
NCT04404881
Ultra-low-dose Chest CT for HHT
Mayo Clinic
NCT04874558
Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia
University of Minnesota
NCT01408732
Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study
The Cleveland Clinic
NCT02287558
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Hereditary Hemorrhagic Telangiectasia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hereditary Hemorrhagic Telangiectasia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hereditary Hemorrhagic Telangiectasia page
8 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Hereditary Hemorrhagic Telangiectasia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Cure HHT sponsors the most Hereditary Hemorrhagic Telangiectasia trials on record, review their full trial history before evaluating a specific study. See Cure HHT's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hereditary Hemorrhagic Telangiectasia condition card totals 8 registered trials; most-linked intervention Sclerotherapy; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.